Erratum to: The influence of antibiotic prophylaxis on bacterial resistance in urinary tract infections in children with spina bifida. [BMC Infect Dis. 17, (2017), (63)] DOI: 10.1186/s12879-016-2166-y;The influence of antibiotic prophylaxis on bacterial resistance in urinary tract infections in children with spina bifida

BMC Infectious Diseases

Volumn 17, Issue 1, 2017, Pages

  Zegers, Sebastiaan Hermanus Johannes ^a   Dieleman, Jeanne ^a   van der Bruggen, Tjomme ^b   Kimpen, Jan ^c   de Jong de Vos van Steenwijk, Catharine ^c   Zegers, Bas ^a  

^a MÁXIMA MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFAZOLIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; LEVOFLOXACIN; MEROPENEM; NITROFURANTOIN; NORFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN; TRIMETHOPRIM; AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIURIA; CHILD; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; HUMAN; INTERMITTENT CATHETERIZATION; LEUKOCYTURIA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; RANDOMIZED CONTROLLED TRIAL; SPINAL DYSRAPHISM; URINARY TRACT INFECTION; URINE CULTURE; ADOLESCENT; COMPLICATION; DEPRESCRIPTION; ESCHERICHIA COLI INFECTIONS; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; ISOLATION AND PURIFICATION; MICROBIOLOGY; PHYSIOLOGY; URINARY TRACT INFECTIONS;

ADOLESCENT; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BACTERIURIA; CHILD; DEPRESCRIPTIONS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; FLUOROQUINOLONES; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; NITROFURANTOIN; PENICILLINS; SPINAL DYSRAPHISM; TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION; URINARY TRACT INFECTIONS;

EID: 85009277241     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-017-2268-1     Document Type: Erratum

References (23)

1. RIVUR Trial Investigators, Hoberman A, Greenfield SP, Mattoo TK, Keren R, Mathews R, Pohl HG, Kropp BP, Skoog SJ, Nelson CP, Moxey-Mims M, Chesney RW, Carpenter MA. Antimicrobial prophylaxis for children with vesicoureteral reflux. N Engl J Med. 2014;370(25):2367-76.
2. Dayan N, Dabbah H, Weissman I, Aga I, Even L, Glikman D. Urinary tract infections caused by community-acquired extended-spectrum beta-lactamase-producing and nonproducing bacteria: a comparative study. J Pediatr. 2013;163(5):1417-21.
3. Ilic K, Jakovljevic E, Skodric-Trifunovic V. Social-economic factors and irrational antibiotic use as reasons for antibiotic resistance of bacteria causing common childhood infections in primary healthcare. Eur J Pediatr. 2012;171(5):767-77.
4. Shepherd AK, Pottinger PS. Management of urinary tract infections in the era of increasing antimicrobial resistance. Med Clin North Am. 2013;97(4):737-57. xii.
5. Beetz R, Westenfelder M. Antimicrobial therapy of urinary tract infections in children. Int J Antimicrob Agents. 2011;38(Suppl):42-50.
6. Pruitt LJ. Living with spina bifida: a historical perspective. Pediatrics. 2012;130(2):181-3.
7. Lapides J. Urinary diversion. Surgery. 1971;69(0039-6060; 0039-6060; 1):142-54.
8. Schlager TA, Dilks S, Trudell J, Whittam TS, Hendley JO. Bacteriuria in children with neurogenic bladder treated with intermittent catheterization: natural history. J Pediatr. 1995;126(0022-3476; 3):490-6.
9. Schlager TA, Anderson S, Trudell J, Hendley JO. Nitrofurantoin prophylaxis for bacteriuria and urinary tract infection in children with neurogenic bladder on intermittent catheterization. J Pediatr. 1998;132(0022-3476; 4):704-8.
10. Dik P, Klijn AJ, van Gool JD, de Jong-de Vos van Steenwijk CC, De Jong TP. Early start to therapy preserves kidney function in spina bifida patients. Eur Urol. 2006;49(0302-2838; 5):908-13.
11. Zegers BS, Winkler-Seinstra PL, Uiterwaal CS, de Jong TV, Kimpen JL, van de Jong-de Vos van Steenwijk CC. Urinary tract infections in children with spina bifida: an inventory of 41 European centers. Pediatr Nephrol. 2009;24(0931-041; 4):783-8.
12. Zegers B, Uiterwaal C, Kimpen J, van Gool J, de Jong T, Winkler-Seinstra P, Houterman S, Verpoorten C, de Jong-de Vos van Steenwijk C. Antibiotic prophylaxis for urinary tract infections in children with spina bifida on intermittent catheterization. J Urol. 2011;186(6):2365-70.
13. Bitsori M, Maraki S, Galanakis E. Long-term resistance trends of uropathogens and association with antimicrobial prophylaxis. Pediatr Nephrol. 2014;29(6):1053-8.
14. Conway PH, Cnaan A, Zaoutis T, Henry BV, Grundmeier RW, Keren R. Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials. JAMA. 2007;298(1538-3598; 2):179-86.
15. Lutter SA, Currie ML, Mitz LB, Greenbaum LA. Antibiotic resistance patterns in children hospitalized for urinary tract infections. Arch Pediatr Adolesc Med. 2005;159(10):924-8.
16. Ladhani S, Gransden W. Increasing antibiotic resistance among urinary tract isolates. Arch Dis Child. 2003;88(1468-2044; 5):444-5.
17. Narchi H, Al-Hamdani M. Uropathogen resistance to antibiotic prophylaxis in urinary tract infections. Microb Drug Resist. 2010;16(1931-8448; 1076-6294; 2):151-4.
18. Nelson CP, Hoberman A, Shaikh N, Keren R, Mathews R, Greenfield SP, Mattoo TK, Gotman N, Ivanova A, Moxey-Mims M, Carpenter MA, Chesney RW: Antimicrobial Resistance and Urinary Tract Infection Recurrence. Pediatrics 2016, 137(4): 10.1542/peds.2015-2490. Epub 2016 Mar 11.
19. Stokes HW, Gillings MR. Gene flow, mobile genetic elements and the recruitment of antibiotic resistance genes into Gram-negative pathogens. FEMS Microbiol Rev. 2011;35(5):790-819.
20. Alekshun MN, Levy SB. Molecular mechanisms of antibacterial multidrug resistance. Cell. 2007;128(6):1037-50.
21. Friedman S, Reif S, Assia A, Mishaal R, Levy I. Clinical and laboratory characteristics of non-E. coli urinary tract infections. Arch Dis Child. 2006;91(10):845-6.
22. Edlin RS, Shapiro DJ, Hersh AL, Copp HL. Antibiotic resistance patterns of outpatient pediatric urinary tract infections. J Urol. 2013;190(1):222-7.
23. Wagenlehner FM, Cek M, Naber KG, Kiyota H, Bjerklund-Johansen TE. Epidemiology, treatment and prevention of healthcare-associated urinary tract infections. World J Urol. 2012;30(1):59-67.